MODIFICATION TO THE EMIT II PLUS METHAQUALONE ASSAY, MODEL OSR9Q229— 510(k) K011164

Name: FDA 510(k) clearance K011164
Creator: U.S. Food and Drug Administration
Published: 2001-05-10

Substantially Equivalent

Syva Co., Dade Behring, Inc.

FDA 510(k) clearance K011164 for MODIFICATION TO THE EMIT II PLUS METHAQUALONE ASSAY, MODEL OSR9Q229, Substantially Equivalent on 2001-05-10. Applicant: Syva Co., Dade Behring, Inc.. Device class: 2.

Clearance details

Applicant: Syva Co., Dade Behring, Inc.
Product code: Code KXS
Device class: Class 2
Regulation: 21 CFR 862.3630
Advisory panel: Clinical Toxicology
Date received: 2001-04-16
Decision date: 2001-05-10
Decision: Substantially Equivalent
Clearance type: Special
Location: San Jose, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KXS

view all

K993986 — SYVA EMIT II PLUS METHAQUALONE ASSAY, MODEL 9Q029UL/9Q129UL2000-01-27
K955676 — SYNCHRON SYSTEMS METHAQUALONE REAGENT1996-03-04
K945187 — ROCHE ABUSCREEN ONLINE FOR METHAQUALONE1995-04-05
K940123 — METHAQUALONE ENZYME IMMUNOASSAY1994-05-03
K921013 — SYVA EMIT II METHAQUALONE ASSAY1992-05-13

More clearances from Syva Co., Dade Behring, Inc.

view all

K011920 — EMIT 2000 DIGOXIN ASSAY, MODEL OSR4H2292001-07-02
K011620 — EMIT 2000 N-ACETYLPROCAINAMIDE ASSAY, MODEL OSR4N2292001-06-18
K011605 — EMIT 2000 QUINIDINE ASSAY, MODEL OSR4Q2292001-06-12
K011300 — EMIT II PLUS CANNABINOID ASSAY, MODEL OSR9N2292001-05-17
K011306 — EMIT II PLUS BENZODIAZEPINE ASSAY, MODEL 0SR9F2292001-05-16

Data sourced from openFDA. This site is unofficial and independent of the FDA.